GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biological Inc (SZSE:301047) » Definitions » Change In Receivables

Sino Biological (SZSE:301047) Change In Receivables : ¥0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Sino Biological Change In Receivables?

Sino Biological's change in receivables for the quarter that ended in Mar. 2024 was ¥0.0 Mil. It means Sino Biological's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Sino Biological's change in receivables for the fiscal year that ended in Dec. 2023 was ¥83.1 Mil. It means Sino Biological's Accounts Receivable declined by ¥83.1 Mil from Dec. 2022 to Dec. 2023 .

Sino Biological's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥139.2 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Sino Biological's Days Sales Outstanding for the three months ended in Mar. 2024 was 83.40.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Sino Biological's liquidation value for the three months ended in Mar. 2024 was ¥4,707.1 Mil.


Sino Biological Change In Receivables Historical Data

The historical data trend for Sino Biological's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biological Change In Receivables Chart

Sino Biological Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial -19.66 -166.35 26.66 21.01 83.15

Sino Biological Quarterly Data
Dec18 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sino Biological Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino Biological  (SZSE:301047) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Sino Biological's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=139.243/152.349*91
=83.40

2. In Ben Graham's calculation of liquidation value, Sino Biological's accounts receivable are only considered to be worth 75% of book value:

Sino Biological's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=4776.916-203.543+0.75 * 139.243+0.5 * 58.554
=4,707.1

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sino Biological Change In Receivables Related Terms

Thank you for viewing the detailed overview of Sino Biological's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Sino Biological (SZSE:301047) Business Description

Traded in Other Exchanges
N/A
Address
No. 18 Kechuang 10th Street, Room 306, Building 9, Beijing Economic and Technological Development Zon, Beijing, CHN, 100176
Sino Biological Inc is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones.

Sino Biological (SZSE:301047) Headlines

No Headlines